APA (7th ed.) Citation

R, P., ME, R., GI, R., DA, R., YZ, P., PM, H., & HA, B. (1999). Phase II trial of docetaxel for cholangiocarcinoma. American journal of clinical oncology, 22(1), 78. https://doi.org/10.1097/00000421-199902000-00019

Chicago Style (17th ed.) Citation

R, Pazdur, Royce ME, Rodriguez GI, Rinaldi DA, Patt YZ, Hoff PM, and Burris HA. "Phase II Trial of Docetaxel for Cholangiocarcinoma." American Journal of Clinical Oncology 22, no. 1 (1999): 78. https://doi.org/10.1097/00000421-199902000-00019.

MLA (9th ed.) Citation

R, Pazdur, et al. "Phase II Trial of Docetaxel for Cholangiocarcinoma." American Journal of Clinical Oncology, vol. 22, no. 1, 1999, p. 78, https://doi.org/10.1097/00000421-199902000-00019.